Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  poly ICLC
Find trials that include:  Any drugs shown
Results 1-13 of 13 for your search:
Start Over
Vaccine Therapy in Treating Patients With Stage I-III Non-Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 11-094, NCI-2013-00081, NCT01720836
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 248613, NCI-2014-00771, NCT02166905
Poly ICLC in Treating Younger Patients With Recurrent or Progressive Low Grade Gliomas
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 0 to 21
Trial IDs: Poly-ICLC, NCI-2013-02084, NCT01188096
Vaccine Therapy in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Phase: Phase II
Type: Treatment
Age: 18 to 80
Trial IDs: UPCC 02710, NCI-2011-02934, NCT01245673
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LUD2012-004, NCI-2013-01366, NCT01810016
Vaccine Therapy in Treating Patients with Stage IIIB-IV Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 13-240, NCI-2014-00958, NCT01970358
Radiation Therapy and Romidepsin with or without Poly ICLC in Treating Patients with Previously Treated Stage IIA-IVA Mycosis Fungoides
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: S13-00686, NCI-2014-00279, i13-00686, NYU S13-00686, NCT02061449
Personalized Vaccine Therapy in Treating Patients with Triple-Negative Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201506113, NCI-2015-01050, NCT02427581
HLA-A2-Restricted Synthetic Glioma Antigen Peptides Vaccine and MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Treating Patients With Brain Tumor
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 07-057, NCI-2011-02465, CDR0000628889, R21CA133859-01A1, NCT00795457
Vaccine Therapy in Treating Patients With Recurrent Gliomas After Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 08-135, NCI-2011-02491, NCT00874861
Vaccine Therapy in Treating Patients with Stage IB-IIIA Breast Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Breast41, NCI-2014-02151, 1134, NCT01532960
Start Over